Thailand approves emergency use of Oxford–AstraZeneca vaccine
Thailand's Food and Drug Administration has approved the emergency use of the Oxford–AstraZeneca COVID-19 vaccine, with 50,000 doses expected to arrive in February. Additional doses will follow in March and April, and local production is expected to begin in May.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan for full access to every Belfast Herald story and the complete archive.
HealthThailand approves emergency use of Oxford–AstraZeneca vaccine
Sign in or subscribeBrowse free archive reportsThailand's Food and Drug Administration has approved the emergency use of the Oxford–AstraZeneca COVID-19 vaccine, with 50,000 doses expected to arrive in February. Additional doses will follow in March and April, and local production is expected to begin in May.